Related references
Note: Only part of the references are listed.Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
Shaoquan Zheng et al.
ONCOIMMUNOLOGY (2022)
Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma
Yi Wang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer
Yang Chen et al.
CANCER CELL (2022)
PODNL1 promotes cell migration and regulates the epithelial/mesenchymal transition process in bladder cancer
Xiao Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Yuze Wu et al.
MOLECULAR CANCER (2022)
TGF-β signaling networks in the tumor microenvironment
Max Kam-Kwan Chan et al.
CANCER LETTERS (2022)
LRG1: an emerging player in disease pathogenesis
Carlotta Camilli et al.
JOURNAL OF BIOMEDICAL SCIENCE (2022)
Lumican inhibits immune escape and carcinogenic pathways in colorectal adenocarcinoma
Yiqing Zang et al.
Aging-US (2021)
PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma
Humaira Noor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
Xiaoding Hu et al.
COMMUNICATIONS BIOLOGY (2021)
CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance
Cheng Wang et al.
CELL STEM CELL (2021)
Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance
Sandeep Appunni et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
The matrix in cancer
Thomas R. Cox
NATURE REVIEWS CANCER (2021)
Evaluation of lumican effects on morphology of invading breast cancer cells, expression of integrins and downstream signaling
Konstantina Karamanou et al.
FEBS JOURNAL (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
Nina Gran Egeland et al.
CLINICAL EPIDEMIOLOGY (2020)
Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data
Jinfen Wei et al.
CANCERS (2020)
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
Alexandre Perrier et al.
BIOMOLECULES (2020)
PODNL1 promotes cell proliferation and migration in glioma via regulating Akt/mTOR pathway
Yibo Geng et al.
JOURNAL OF CANCER (2020)
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan
Claire Vennin et al.
NATURE COMMUNICATIONS (2019)
Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer
Yaozong Wang et al.
PEERJ (2019)
CD10+ GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su et al.
CELL (2018)
COL5A1 may contribute the metastasis of lung adenocarcinoma
Weibo Liu et al.
GENE (2018)
Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
Ellen Pure et al.
ONCOGENE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
Ankur Chakravarthy et al.
NATURE COMMUNICATIONS (2018)
Low expression of microRNA-1908 predicts a poor prognosis for patients with ovarian cancer
Changcai Teng et al.
ONCOLOGY LETTERS (2017)
Stromal Modulators of TGF-β in Cancer
Brunella Costanza et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
Tumor microenvironment and therapeutic response
Ting Wu et al.
CANCER LETTERS (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer
Megan Agajanian et al.
PLOS ONE (2015)
Extracellular Lumican Inhibits Pancreatic Cancer Cell Growth and Is Associated with Prolonged Survival after Surgery
Xinqun Li et al.
CLINICAL CANCER RESEARCH (2014)
The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly
Shoujun Chen et al.
FEBS JOURNAL (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Podocan-like protein: A novel small leucine-rich repeat matrix protein in bone
Yoshiyuki Mochida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction
Liliana Schaefer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Decorin-transforming growth factor-β interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices
Zannatul Ferdous et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A novel modulatory mechanism of transforming growth factor-ß signaling through decorin and LRP-1
Claudio Cabello-Verrugio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
BW Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)